Dolly Parton helped fund Moderna's Covid-19 vaccine research
In April, less than a month after Covid-19 was officially declared a pandemic, Dolly Parton donated $1 million to coronavirus research at Vanderbilt University.
More than seven months later, it's been revealed that the legendary performer's donation helped fund Moderna's Covid-19 vaccine, which this week became the second coronavirus vaccine with a stunningly high success rate.
Parton's name appears in the preliminary report on the vaccine among sponsors like the National Institute of Allergy and Infectious Diseases, which Dr. Anthony Fauci heads, and Emory University. She originally donated to Vanderbilt University Medical Center in honor of her friend and Vanderbilt professor of surgery Dr. Naji Abumrad.
The Moderna vaccine is 94.5% effective against coronavirus, according to early data released this week by the company. Vaccinations could begin as soon as late December, Fauci said, though they'll be made available first to high-risk groups like health care workers, the elderly and people with underlying medical conditions.
Covid-19 has surged since Parton first made her donation. Then, there were just over 200,000 reported Covid-19 cases in the US. Now, there are over 11.2 million cases and nearly 250,000 Americans have died.
Parton recognized then the severity of the virus and urged her fans to donate to Vanderbilt Health's Covid-19 research fund, which has raised more than $98,000 of its $250,000 goal.
Her gift was first used toward research for interim Covid-19 treatments while the vaccine was being developed, she said in an April appearance on NBC's "Today."
"I felt like this was the time for me to open my heart and my hand and try to help," she said in her "Today" appearance.
CNN has reached out to Moderna and representatives for Parton and is waiting to hear back.
Parton's name appears in the preliminary report on the vaccine among sponsors like the National Institute of Allergy and Infectious Diseases, which Dr. Anthony Fauci heads, and Emory University. She originally donated to Vanderbilt University Medical Center in honor of her friend and Vanderbilt professor of surgery Dr. Naji Abumrad.
The Moderna vaccine is 94.5% effective against coronavirus, according to early data released this week by the company. Vaccinations could begin as soon as late December, Fauci said, though they'll be made available first to high-risk groups like health care workers, the elderly and people with underlying medical conditions.
Covid-19 has surged since Parton first made her donation. Then, there were just over 200,000 reported Covid-19 cases in the US. Now, there are over 11.2 million cases and nearly 250,000 Americans have died.
Parton recognized then the severity of the virus and urged her fans to donate to Vanderbilt Health's Covid-19 research fund, which has raised more than $98,000 of its $250,000 goal.
Her gift was first used toward research for interim Covid-19 treatments while the vaccine was being developed, she said in an April appearance on NBC's "Today."
"I felt like this was the time for me to open my heart and my hand and try to help," she said in her "Today" appearance.
CNN has reached out to Moderna and representatives for Parton and is waiting to hear back.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.